Intensive Safety Monitoring of Rituximab (Biosimilar Novex® and the Innovator) in Pediatric Patients With Complex Diseases

Overview of attention for article published in Frontiers in Pharmacology, January 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

So far, Dimensions has found 3 publications that cite this research output.

Article in Expert Opinion on Biological Therapy (September 2024)

Article in Pharmaceutics (October 2023)

Article in Reactions Weekly (January 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.